English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17778/20119 (88%)
Visitors : 12227247      Online Users : 263
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/28647

    標題: Plasma apelin: A novel biomarker for predicting diabetes
    作者: Ma, Wen-Ya
    Yu, Tse-Ya
    Wei, Jung-Nan
    Hung, Chi-Sheng
    Lin, Mao-Shin
    Liao, Ying-Jhu
    Pei, Dee
    Su, Ching-Chieh
    Lu, Kuo-Cheng
    Liu, Pi-Hua
    Lin, Cheng-Hsin
    Chuang, Lee-Ming
    Kao, Hsien-Li
    Lin, Jou-Wei
    Chuang, Ya-Ju
    Li, Hung-Yuan
    貢獻者: 職業安全衛生系
    關鍵字: Apelin
    日期: 2014-08
    上傳時間: 2015-05-06 21:23:45 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: Background: Apelin regulates insulin sensitivity and secretion in animals. However, whether plasma apelin predicts incident diabetes in humans remains unknown. Methods: We studied a cohort including 447 subjects (148 men, 299 women) without diabetes and followed for an average of 3 y. Diabetes was diagnosed by an oral glucose tolerance test, plasma hemoglobin A1c, and if the subject was taking medications for diabetes. Plasma apelin-12 at baseline was measured with a commercial kit. Results: Plasma apelin concentrations were higher in women than in men at baseline (p = 0.007). During follow-up, 43 subjects developed type 2 diabetes. Higher plasma apelin concentrations were associated with a higher risk of diabetes in men (p = 0.049) but not in women. Plasma apelin predicted incident type 2 diabetes in men (hazard ratio, 2.13, 95% CI 1.29-3.51, p < 0.05), but not in women, adjusted for age, family history of diabetes, hemoglobin A1c, body mass index, hypertension, and HOMA2-IR. Apelin could improve the prediction ability beyond traditional risk factors in men, and the sensitivity and specificity of plasma apelin at 0.9 ng/ml for this prediction were 63.2% and 58.9%, respectively. In men at risk for diabetes (HbA1c 5.7-6.4%, FPG 100-125 mg/dl, or OGIT-2 h-PG 140-199 mg/dl), the risk for developing diabetes was higher in those with higher plasma apelin concentration than in those with lower plasma apelin concentrations (10.6%/year vs. 5.1%/year, p < 0.001). Conclusions: Plasma apelin is a novel biomarker for predicting type 2 diabetes in men. (C) 2014 Elsevier B.V. All rights reserved.
    關聯: Clinica Chimica Acta, v.435, pp.18-23
    Appears in Collections:[職業安全衛生系(含防災所)] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback